These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8390080)
1. Oxytocin antagonists and their therapeutic use. Melin P Regul Pept; 1993 Apr; 45(1-2):285-8. PubMed ID: 8390080 [No Abstract] [Full Text] [Related]
2. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea. Akerlund M; Melin P; Maggi M Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023 [TBL] [Abstract][Full Text] [Related]
3. Oxytocin receptor blockade: a new principle in the treatment of preterm labor? Andersen LF; Lyndrup J; Akerlund M; Melin P Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760 [TBL] [Abstract][Full Text] [Related]
9. Profile of an oxytocin antagonist, RWJ 22164 for treatment of preterm labor in laboratory models of uterine contractility. Demarest KT; Hahn DW; Ericson E; Capetola RJ; Fuchs AR; McGuire JL Am J Perinatol; 1989 Apr; 6(2):200-4. PubMed ID: 2712917 [TBL] [Abstract][Full Text] [Related]
10. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Higby K; Xenakis EM; Pauerstein CJ Am J Obstet Gynecol; 1993 Apr; 168(4):1247-56; discussion 1256-9. PubMed ID: 8097367 [TBL] [Abstract][Full Text] [Related]
11. Comparison of binding affinity of oxytocin antagonists to human and rat uterine oxytocin receptors and their correlation to the rat uterine oxytocic bioassay. Pak SC; Bertoncini D; Meyer W; Scaunas D; Flouret G; Wilson L Biol Reprod; 1994 Dec; 51(6):1140-4. PubMed ID: 7888492 [TBL] [Abstract][Full Text] [Related]
12. [Effect of maternal pharmacological treatment of preterm delivery for neonatal condition]. Kornacka MK Med Wieku Rozwoj; 2003; 7(3 Suppl 1):115-21. PubMed ID: 15537251 [TBL] [Abstract][Full Text] [Related]
13. Discovery and development of non-peptide antagonists of peptide hormone receptors. Pettibone DJ; Freidinger RM Biochem Soc Trans; 1997 Aug; 25(3):1051-7. PubMed ID: 9388600 [No Abstract] [Full Text] [Related]
14. Noncompetitive nature of oxytocin antagonists with general structure Mpa(1)Xxx(2)Sar(7)Arg(8). Havass J; Bakos K; Márki A; Gáspár R; Gera L; Stewart JM; Fülöp F; Tóth GK; Zupkó I; Falkay G Peptides; 2002 Aug; 23(8):1419-25. PubMed ID: 12182942 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of spontaneous uterine contractions during the last trimester in pregnant baboons by an oxytocin antagonist. Wilson L; Parsons MT; Flouret G Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1875-82. PubMed ID: 2256498 [TBL] [Abstract][Full Text] [Related]
16. Progress in the development of oxytocin antagonists for use in preterm labor. Williams PD; Bock MG; Evans BE; Freidinger RM; Pettibone DJ Adv Exp Med Biol; 1998; 449():473-9. PubMed ID: 10026841 [TBL] [Abstract][Full Text] [Related]
17. 1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor. Williams PD; Anderson PS; Ball RG; Bock MG; Carroll L; Chiu SH; Clineschmidt BV; Culberson JC; Erb JM; Evans BE J Med Chem; 1994 Mar; 37(5):565-71. PubMed ID: 8126695 [TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction. Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106 [TBL] [Abstract][Full Text] [Related]
20. Progress in the development of oxytocin antagonists for use in preterm labor. Pettibone DJ; Guidotti M; Harrell CM; Jasper JR; Lis EV; O'Brien JA; Reiss DR; Woyden CJ; Bock MG; Evans BE Adv Exp Med Biol; 1995; 395():601-12. PubMed ID: 8714024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]